@ Amsterdam’s House of Stories….The Mezrab
Veemkade 576,
1019 BL AMSTERDAM
Monday Dec 6
Jeremy Weate
– A History of Ibogaine
Dana Beal
– Ibogaine 101
Martie Underwood
Exploring the Structure of the Ibogaine State of Consciousness
I will present the findings from my quantitative study conducted in 2020-2021. I used the Phenomenology of Consciousness Inventory, which illuminated key aspects of the structure of consciousness during the ibogaine experience, and also compares the ibogaine experience to other states of consciousness.
Roman Paskulin
– new findings
Tobias Erny
– Micro-dose ibogaine for Parkinson’s.
Ibogaine stimulates a sustained increase in Glial cell line-derived neurotrophic factor (GDNF) expression in the brain. GDNF has been shown to increase survival, functioning and sprouting of dopamine neurons in a variety of animal models and human trials. This is particular interesting for the treatment of Parkinson’s Disease (PD). Furthermore, the metabolite of Ibogaine, i.e. Noribogaine acts as a selective serotonin reuptake inhibitor (SSRI) which helps to brighten the mood and counteracts the depressive element of PD. Our pre-clinical observational case report study proofs that Ibogaine alleviates PD symptoms and increases the overall living quality of PD patients.
Dr Eugene Schoenfeld
Recollections of Lamborini
Tuesday Dec 7
Andrea Langlois ICEERS
– sustainable ibogaine panel
+ Jean Nicholas
Brid Ni Fhoighil
– Iboga in Netherlands Today
David Subeliani
– Opening clinics in new countries
Anders Beatty
– Pre-care considerations and
Spero Alexio
– Beating the Odds w. Aftercare
Clare Wilkins
– Treating fentanyl , research Chem opioids, the buprenorphine implant
Wednesday Dec. 8
Enrico Fletzer
– The cases of Jan Bastiaans, Howard Lotsof, Sara Glatt & Anwar Jeewa
+ Robbert Jonk
Dr Jeffrey Kamlet
– A review of all fatalities temporally related
Juliana Mulligan
– Ibogaine Today
Rocky Caravelli
– ibogaine for Meth-amphetamine
+Jasen Chamoun
Rick Doblin
– focus on ibogaine development
